The drug inhibition of increased vascular permeability.
D000818:Animals; D001808:Blood Vessels / Q000503:physiopathology*; D002056:Burns / Q000188:drug therapy*; D002199:Capillary Permeability / Q000187:drug effects; D002746:Chlorpromazine / Q000627:therapeutic use; D004077:Digoxin / Q000627:therapeutic use; D004155:Diphenhydramine / Q000627:therapeutic use; D007213:Indomethacin / Q000627:therapeutic use; D007249:Inflammation / Q000139:chemically induced / Q000188:drug therapy; D008297:Male; D010539:Permeability; D011398:Promethazine / Q000627:therapeutic use*; D011803:Quinine / Q000627:therapeutic use; D051381:Rats; D012459:Salicylates / Q000627:therapeutic use; D013328:Strophanthins / Q000627:therapeutic use; D014020:Tissue Extracts; D014425:Turpentine
D012459:Salicylates; D013328:Strophanthins; D014020:Tissue Extracts; D004077:Digoxin; D004155:Diphenhydramine; D011803:Quinine; D011398:Promethazine; D002746:Chlorpromazine; D014425:Turpentine; D007213:Indomethacin